You have 9 free searches left this month | for more free features.

Microglia

Showing 1 - 25 of 301

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Using IMC to Analyze the Impact of ICANS on Microglia

Recruiting
  • ICANS, Grade Unspecified
  • CAR T-Cell-Related Encephalopathy Syndrome
  • There will be no intervention as we will study patients that undergo autopsy after CAR T cell infusion.
  • Freiburg, Baden Württemberg, Germany
    Freiburg University Medical Center
Apr 12, 2023

Selective PET Imaging of Astrocytes and Microglia in Alzheimer's

Recruiting
  • Alzheimer Disease
  • Healthy
  • Positron Emission Tomography (PET) using two PET tracer under IND
  • Houston, Texas
    Houston Methodist Research Institute
Jan 20, 2023

Microglia in the Pathogenesis of Progressive Multiple Sclerosis

Active, not recruiting
  • Multiple Sclerosis
    • Turku, Finland Proper, Finland
      Turku PET Centre
    Oct 12, 2022

    Microglia Activation in Asthma

    Recruiting
    • Asthma
    • Whole lung antigen challenge (WLAC)
    • [18F]FEPPA
    • Madison, Wisconsin
      University of Wisconsin Madison
    Jul 14, 2022

    REM Sleep Behavior Disorder Trial in Camperdown, Oxford (PXS-4728 (A), Matching Placebo (B))

    Not yet recruiting
    • REM Sleep Behavior Disorder
    • PXS-4728 (A)
    • Matching Placebo (B)
    • Camperdown, Sydney, Australia
    • +1 more
    Jun 6, 2023

    Secondary-progressive Multiple Sclerosis Trial in Buffalo (Mayzent, Ocrevus)

    Recruiting
    • Secondary-progressive Multiple Sclerosis
    • Buffalo, New York
      University at Buffalo, Buffalo General Hospital
    Oct 10, 2022

    Glioblastoma Trial (PET imaging)

    Not yet recruiting
    • Glioblastoma
    • PET imaging
    • (no location specified)
    Feb 23, 2023

    Alzheimer Trial in New Haven (LPS)

    Recruiting
    • Alzheimer Disease
    • New Haven, Connecticut
      Alzheimer's Disease Research Unit
    Feb 8, 2022

    Measuring Active Microglia in Progressive Multiple Sclerosis

    Completed
    • Secondary Progressive Multiple Sclerosis
    • [C11]PK-1195 PET scan
    • New York, New York
      Weill Cornell Medical College
    Jan 14, 2022

    Gulf War Illness Trial in Birmingham (Boswellia Serrata, Curcumin, Epimedium)

    Active, not recruiting
    • Gulf War Illness
    • Boswellia Serrata
    • +9 more
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Nov 17, 2021

    Examining Neuroinflammation in AlzHeimer's

    Enrolling by invitation
    • Alzheimer Disease, Early-Onset
      • (no location specified)
      Feb 15, 2022

      Hypertension Trial in Gainesville (Minocycline)

      Not yet recruiting
      • Hypertension
      • Gainesville, Florida
        UF Health Cardiovascular Clinic
      Nov 12, 2021

      Amyotrophic Lateral Sclerosis Trial in Finland, Sweden, United States (BLZ945)

      Recruiting
      • Amyotrophic Lateral Sclerosis
      • New Haven, Connecticut
      • +4 more
      Aug 22, 2022

      Relapsing Multiple Sclerosis Trial in Boston (Ofatumumab, [F-18]PBR06)

      Recruiting
      • Relapsing Multiple Sclerosis
      • Boston, Massachusetts
        Partners MS Center, 60 Fenwood Road
      Jul 20, 2021

      CBD, Healthy Trial in New Haven ([11C]PBR28, Low-dose lipopolysaccharide, Intradermal Capsaicin)

      Recruiting
      • CBD
      • Healthy
      • [11C]PBR28
      • +2 more
      • New Haven, Connecticut
        Connecticut Mental Health Center
      Sep 3, 2021

      Retinal Vein Occlusion Trial in Bethesda, Bristol (Minocycline, Placebo, Bevacizumab)

      Completed
      • Retinal Vein Occlusion
      • Bethesda, Maryland
      • +1 more
      Dec 27, 2021

      Glioma Microenvironment and Function and Visualization of

      Recruiting
      • Glioma
      • surgery
      • Shanghai, China
        Huashan Hospital,Fudan University
      Mar 22, 2021

      Retinal Vein Occlusion Trial in Bethesda, Bristol (Minocycline, Placebo, Bevacizumab)

      Completed
      • Retinal Vein Occlusion
      • Bethesda, Maryland
      • +1 more
      Feb 25, 2021

      Schizophrenia Trial in Utrecht (Placebo, Cannabidiol)

      Completed
      • Schizophrenia
      • Utrecht, Netherlands
        University Medical Center Utrecht
      Mar 26, 2020

      Diabetic Macular Edema Trial run by the NEI (Dextromethorphan hydrobromide)

      Completed
      • Diabetic Macular Edema
      • Dextromethorphan hydrobromide
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jul 20, 2020

      Alzheimer Trial in Paris (Placebo, Masitinib (4.5), Standard of care)

      Not yet recruiting
      • Alzheimer Disease
      • Placebo
      • +2 more
      • Paris, France
        Institut de la mémoire et Maladie d'Alzheimer, Hôpitaux Universi
      Sep 29, 2022

      HIV Associated Neurocognitive Disorder, HIV Dementia, HIV Encephalitis Trial (SV2A PET, TSPO PET)

      Not yet recruiting
      • HIV Associated Neurocognitive Disorder
      • +3 more
      • SV2A PET
      • TSPO PET
      • (no location specified)
      Oct 16, 2022

      Alzheimer Trial in Boston (Transcranial Alternating Current Stimulation (tACS))

      Completed
      • Alzheimer Disease
      • Transcranial Alternating Current Stimulation (tACS)
      • Boston, Massachusetts
        Beth Israel Deaconess Medical Center
      Feb 2, 2022

      Alzheimer Trial in New York (11C-ER176, 18F-florbetaben)

      Recruiting
      • Alzheimer Disease
      • New York, New York
        Columbia University Irving Medical Center
      Jan 10, 2022

      SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill

      Active, not recruiting
      • COVID-19 Disease
      • Data collection from lumbar puncture
      • +3 more
      • Basel, Switzerland
        Neurosurgery, University Hospital Basel
      Nov 1, 2021